These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 27163230

  • 1. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
    Lv Q, Rong N, Liu LJ, Xu XL, Liu JT, Jin FX, Wang CM.
    Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
    [Abstract] [Full Text] [Related]

  • 2. Anticancer property of ginsenoside Rh2 from ginseng.
    Li X, Chu S, Lin M, Gao Y, Liu Y, Yang S, Zhou X, Zhang Y, Hu Y, Wang H, Chen N.
    Eur J Med Chem; 2020 Oct 01; 203():112627. PubMed ID: 32702586
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Chen W, Qiu Y.
    Cell Biochem Biophys; 2015 Jun 01; 72(2):325-31. PubMed ID: 25561284
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.
    Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N.
    Jpn J Cancer Res; 1998 Jul 01; 89(7):733-40. PubMed ID: 9738980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The immunomodulatory effects of ginsenoside derivative Rh2-O on splenic lymphocytes in H22 tumor-bearing mice is partially mediated by TLR4.
    Wu HC, Hu QR, Luo T, Wei WC, Wu HJ, Li J, Zheng LF, Xu QY, Deng ZY, Chen F.
    Int Immunopharmacol; 2021 Dec 01; 101(Pt B):108316. PubMed ID: 34768129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells.
    Chen C, Wang YS, Zhang ET, Li GA, Liu WY, Li Y, Jin YH.
    Int J Mol Sci; 2021 Dec 06; 22(23):. PubMed ID: 34884975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721].
    Zeng XL, Tu ZG.
    Ai Zheng; 2004 Aug 06; 23(8):879-84. PubMed ID: 15301707
    [Abstract] [Full Text] [Related]

  • 19. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
    Xi S, Peng Y, Minuk GY, Shi M, Fu B, Yang J, Li Q, Gong Y, Yue L, Li L, Guo J, Peng Y, Wang Y.
    J Ethnopharmacol; 2016 Aug 22; 190():1-12. PubMed ID: 27235019
    [Abstract] [Full Text] [Related]

  • 20. Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells.
    Xi S, Hong R, Huang J, Lu D, Qian L, Li P, Wen L, Wang Y.
    Afr J Tradit Complement Altern Med; 2014 Aug 22; 11(4):94-100. PubMed ID: 25392588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.